{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:11:58Z","timestamp":1790856718045,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tumor lipid metabolism has emerged as a critical, yet underexplored, determinant of cancer progression with clinical and prognostic importance. A membrane lipid species of particular interest is globotriaosylceramide (Gb\n                      <jats:sub>3<\/jats:sub>\n                      \/CD77), a glycosphingolipid that serves as cellular receptor for the bacterial Shiga toxins, and is upregulated in various malignancies. While preclinical studies have suggested a pro-tumorigenic role for Gb\n                      <jats:sub>3<\/jats:sub>\n                      , the regulatory drivers of its biosynthesis in human tumors have remained elusive.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The glycosyltransferase A4GALT, responsible for Gb\n                      <jats:sub>3<\/jats:sub>\n                      biosynthesis, and the degrading enzyme \u03b1-galactosidase A (\u03b1-GLA) are two essential molecular determinants of Gb\n                      <jats:sub>3<\/jats:sub>\n                      cell surface expression. Expression of these enzymes was analyzed on mRNA level in tissues from colorectal cancer, published datasets from gastric, pancreatic, esophageal and colorectal cancer (1213 patients) and in human cell lines. Pharmacological manipulation in vitro using the hypomethylating agent 5-Aza-2-deoxycytidine and histone deacetylase (HDAC) inhibitors induced A4GALT expression in DLD1 colon cancer cells and Gb\n                      <jats:sub>3<\/jats:sub>\n                      biosynthesis. A4GALT deficiency was induced by CRISPR-Cas9 mutagenesis in human HCT116 colon cancer cells, and its putative effects tested for proliferation, cell migration and invasion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A4GALT deficiency in HCT116 cells confirmed its essential role for Gb\n                      <jats:sub>3<\/jats:sub>\n                      biosynthesis, leading to resistance against Shiga toxin 1a, and to reduced cancer cell migration and invasion. Gene enrichment analyses revealed that high A4GALT and low \u03b1-GLA expression is associated with a distinct gene expression program in gastric, pancreatic and colorectal cancer, including increased signatures of epithelial\u2013mesenchymal transition. A4GALT expression is regulated by chromatin accessibility and DNA methylation at a defined intronic enhancer. In accordance, pan\u2011cancer analysis of TCGA datasets validated the A4GALT\u2011high\/\u03b1\u2011GLA\u2011low signature as a negative prognostic indicator across gastrointestinal tumor entities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our study uncovers an epigenetically regulated lipid metabolic axis involving A4GALT and Gb\n                      <jats:sub>3<\/jats:sub>\n                      that contributes to aggressive tumor behavior. Of note, this pathway may be therapeutically targetable using natural or synthetic Shiga toxin B-subunit derivatives.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-15600-7","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:47:58Z","timestamp":1769503678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Gb3-synthase A4GALT is an epigenetically regulated driver of tumor invasiveness in gastrointestinal cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Noah-David","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Holzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Barz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"En\u00dfle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Widya","family":"Johannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas J.","family":"Unterholzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Obermeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Tschurtschenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Johannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Peter","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"1","key":"15600_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"3","key":"15600_CR2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1053\/j.gastro.2021.05.009","volume":"161","author":"J Ecker","year":"2021","unstructured":"Ecker J, et al. The colorectal cancer lipidome: identification of a robust tumor-specific lipid species signature. Gastroenterology. 2021;161(3):910-923 e19.","journal-title":"Gastroenterology"},{"issue":"5","key":"15600_CR3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1535-7163.MCT-15-0633","volume":"15","author":"PE Geyer","year":"2016","unstructured":"Geyer PE, et al. Gastric adenocarcinomas express the glycosphingolipid Gb3\/CD77: targeting of gastric cancer cells with Shiga toxin B-subunit. Mol Cancer Ther. 2016;15(5):1008\u201317.","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"15600_CR4","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1158\/1535-7163.MCT-11-0006","volume":"10","author":"M Maak","year":"2011","unstructured":"Maak M, et al. Tumor-specific targeting of pancreatic cancer with Shiga toxin B-subunit. Mol Cancer Ther. 2011;10(10):1918\u201328.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"15600_CR5","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-08-0430","volume":"7","author":"T Falgui\u00e8res","year":"2008","unstructured":"Falgui\u00e8res T, et al. Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool. Mol Cancer Ther. 2008;7(8):2498\u2013508.","journal-title":"Mol Cancer Ther"},{"issue":"14","key":"15600_CR6","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1158\/0008-5472.CAN-06-0631","volume":"66","author":"K-P Janssen","year":"2006","unstructured":"Janssen K-P, et al. In vivo tumor targeting using a novel intestinal pathogen-based delivery approach. Cancer Res. 2006;66(14):7230\u20136.","journal-title":"Cancer Res"},{"issue":"3","key":"15600_CR7","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"15600_CR8","first-page":"5314","volume":"53","author":"M Mangeney","year":"1993","unstructured":"Mangeney M, et al. Apoptosis induced in Burkitt\u2019s lymphoma cells via Gb3\/CD77, a glycolipid antigen. Cancer Res. 1993;53(21):5314\u20139.","journal-title":"Cancer Res"},{"issue":"5","key":"15600_CR9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5483\/BMBRep.2009.42.5.310","volume":"42","author":"IS Shin","year":"2009","unstructured":"Shin IS, et al. Globotriaosylceramide (Gb3) content in HeLa cells is correlated to Shiga toxin-induced cytotoxicity and Gb3 synthase expression. BMB Rep. 2009;42(5):310\u20134.","journal-title":"BMB Rep"},{"issue":"10","key":"15600_CR10","first-page":"553","volume":"9","author":"S Arab","year":"1997","unstructured":"Arab S, et al. Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias. Oncol Res. 1997;9(10):553\u201363.","journal-title":"Oncol Res"},{"key":"15600_CR11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2407-9-67","volume":"9","author":"D Johansson","year":"2009","unstructured":"Johansson D, et al. Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis. BMC Cancer. 2009;9:67.","journal-title":"BMC Cancer"},{"key":"15600_CR12","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1186\/1471-2407-14-916","volume":"14","author":"L Stimmer","year":"2014","unstructured":"Stimmer L, et al. Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds. BMC Cancer. 2014;14:916.","journal-title":"BMC Cancer"},{"issue":"4","key":"15600_CR13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/1535-7163.MCT-21-0445","volume":"21","author":"M Ehrenfeld","year":"2022","unstructured":"Ehrenfeld M, et al. Tumor targeting with bacterial Shiga toxin B subunit in genetic porcine models for colorectal cancer and osteosarcoma. Mol Cancer Ther. 2022;21(4):686\u201399.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"15600_CR14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.patbio.2015.03.001","volume":"63","author":"C Picard","year":"2015","unstructured":"Picard C, et al. Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome. Pathol Biol (Paris). 2015;63(3):136\u201343.","journal-title":"Pathol Biol (Paris)"},{"issue":"7","key":"15600_CR15","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/bi971806n","volume":"37","author":"H Ling","year":"1998","unstructured":"Ling H, et al. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry. 1998;37(7):1777\u201388.","journal-title":"Biochemistry"},{"issue":"1","key":"15600_CR16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1039\/C4SM01673D","volume":"11","author":"V Solovyeva","year":"2015","unstructured":"Solovyeva V, Johannes L, Simonsen AC. Shiga toxin induces membrane reorganization and formation of long range lipid order. Soft Matter. 2015;11(1):186\u201392.","journal-title":"Soft Matter"},{"issue":"7170","key":"15600_CR17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nature05996","volume":"450","author":"W Romer","year":"2007","unstructured":"Romer W, et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature. 2007;450(7170):670\u20135.","journal-title":"Nature"},{"issue":"7","key":"15600_CR18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cell.2008.12.009","volume":"135","author":"L Johannes","year":"2008","unstructured":"Johannes L, Popoff V. Tracing the retrograde route in protein trafficking. Cell. 2008;135(7):1175\u201387.","journal-title":"Cell"},{"issue":"2","key":"15600_CR19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2310\/7290.2010.00030","volume":"10","author":"O Couture","year":"2011","unstructured":"Couture O, et al. Tumor delivery of ultrasound contrast agents using Shiga toxin B subunit. Mol Imaging. 2011;10(2):135\u201343.","journal-title":"Mol Imaging"},{"issue":"2","key":"15600_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrmicro2279","volume":"8","author":"L Johannes","year":"2010","unstructured":"Johannes L, R\u00f6mer W. Shiga toxins\u2013from cell biology to biomedical applications. Nat Rev Microbiol. 2010;8(2):105\u201316.","journal-title":"Nat Rev Microbiol"},{"key":"15600_CR21","doi-asserted-by":"crossref","first-page":"813637","DOI":"10.3389\/fmolb.2022.813637","volume":"9","author":"AB Celi","year":"2022","unstructured":"Celi AB, et al. Role of globotriaosylceramide in physiology and pathology. Front Mol Biosci. 2022;9:813637.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"15600_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s11658-024-00658-7","volume":"29","author":"K Szymczak-Kulus","year":"2024","unstructured":"Szymczak-Kulus K, Czerwinski M, Kaczmarek R. Human Gb3\/CD77 synthase: a glycosyltransferase at the crossroads of immunohematology, toxicology, and cancer research. Cell Mol Biol Lett. 2024;29(1):137.","journal-title":"Cell Mol Biol Lett"},{"issue":"9647","key":"15600_CR23","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ. Fabry\u2019s disease. Lancet. 2008;372(9647):1427\u201335.","journal-title":"Lancet"},{"issue":"52","key":"15600_CR24","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1073\/pnas.0506474102","volume":"102","author":"O Kovbasnjuk","year":"2005","unstructured":"Kovbasnjuk O, et al. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc Natl Acad Sci U S A. 2005;102(52):19087\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"15600_CR25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1096\/fba.2020-00044","volume":"2","author":"KR Roy","year":"2020","unstructured":"Roy KR, et al. Gb3-cSrc complex in glycosphingolipid-enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via \u03b2-catenin-activated RNA methylation. FASEB Bioadv. 2020;2(11):653\u201367.","journal-title":"FASEB Bioadv"},{"issue":"11","key":"15600_CR26","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1158\/0008-5472.CAN-17-2223","volume":"78","author":"F Jacob","year":"2018","unstructured":"Jacob F, et al. Transition of mesenchymal and epithelial cancer cells depends on \u03b11-4 galactosyltransferase-mediated glycosphingolipids. Cancer Res. 2018;78(11):2952\u201365.","journal-title":"Cancer Res"},{"issue":"7","key":"15600_CR27","doi-asserted-by":"crossref","first-page":"111181","DOI":"10.1016\/j.celrep.2022.111181","volume":"40","author":"C Cumin","year":"2022","unstructured":"Cumin C, et al. Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways. Cell Rep. 2022;40(7):111181.","journal-title":"Cell Rep"},{"issue":"9","key":"15600_CR28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4161\/cbt.5.9.3173","volume":"5","author":"D Johansson","year":"2006","unstructured":"Johansson D, et al. Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines. Cancer Biol Ther. 2006;5(9):1211\u20137.","journal-title":"Cancer Biol Ther"},{"key":"15600_CR29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fimmu.2019.00090","volume":"10","author":"T Zhang","year":"2019","unstructured":"Zhang T, et al. The role of glycosphingolipids in immune cell functions. Front Immunol. 2019;10:90.","journal-title":"Front Immunol"},{"issue":"12","key":"15600_CR30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMp1607591","volume":"375","author":"RL Grossman","year":"2016","unstructured":"Grossman RL, et al. Toward a shared vision for cancer genomic data. N Engl J Med. 2016;375(12):1109\u201312.","journal-title":"N Engl J Med"},{"issue":"6352","key":"15600_CR31","doi-asserted-by":"crossref","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen M, et al. A pathology atlas of the human cancer transcriptome. Science. 2017;357(6352):eaan2507.","journal-title":"Science"},{"key":"15600_CR32","unstructured":"Team, R.C. A Language and Environment for Statistical Computing. 2024; Available from: https:\/\/www.R-project.org\/."},{"issue":"19","key":"15600_CR33","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1093\/bioinformatics\/btx346","volume":"33","author":"B Gel","year":"2017","unstructured":"Gel B, Serra E. KaryoploteR: an R\/Bioconductor package to plot customizable genomes displaying arbitrary data. Bioinformatics. 2017;33(19):3088\u201390.","journal-title":"Bioinformatics"},{"issue":"12","key":"15600_CR34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"15600_CR35","volume-title":"Emir Turkes, Benjamin Ostendorf, Andrea Grioni","author":"SR Kevin Blighe","year":"2025","unstructured":"Kevin Blighe SR. Emir Turkes, Benjamin Ostendorf, Andrea Grioni. Myles Lewis EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling; 2025."},{"issue":"5","key":"15600_CR36","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"3","key":"15600_CR37","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. Clusterprofiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2(3):100141.","journal-title":"Innovation (Camb)"},{"issue":"6","key":"15600_CR38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"3","key":"15600_CR39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.18632\/oncotarget.1782","volume":"5","author":"H Li","year":"2014","unstructured":"Li H, et al. Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers. Oncotarget. 2014;5(3):587\u201398.","journal-title":"Oncotarget"},{"issue":"7968","key":"15600_CR40","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41586-023-06084-7","volume":"619","author":"AS Agustinus","year":"2023","unstructured":"Agustinus AS, et al. Epigenetic dysregulation from chromosomal transit in micronuclei. Nature. 2023;619(7968):176\u201383.","journal-title":"Nature"},{"key":"15600_CR41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12688\/f1000research.29032.2","volume":"10","author":"F Molder","year":"2021","unstructured":"Molder F, et al. Sustainable data analysis with snakemake. F1000Res. 2021;10:33.","journal-title":"F1000Res"},{"issue":"17","key":"15600_CR42","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, et al. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34(17):i884\u201390.","journal-title":"Bioinformatics"},{"issue":"4","key":"15600_CR43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357\u20139.","journal-title":"Nat Methods"},{"issue":"2","key":"15600_CR44","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek P, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10(2):giab008.","journal-title":"Gigascience"},{"key":"15600_CR45","unstructured":"Institute B, Picard Tools. 2018: broad institute, GitHub repository. https:\/\/broadinstitute.github.io\/picard\/."},{"issue":"Web Server issu","key":"15600_CR46","doi-asserted-by":"crossref","first-page":"W187","DOI":"10.1093\/nar\/gku365","volume":"42","author":"F Ramirez","year":"2014","unstructured":"Ramirez F, et al. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 2014;42(Web Server issue):W187-91.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"15600_CR47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13059-018-1597-8","volume":"20","author":"S Lee","year":"2019","unstructured":"Lee S, Cook D, Lawrence M. plyranges: a grammar of genomic data transformation. Genome Biol. 2019;20(1):4.","journal-title":"Genome Biol"},{"issue":"6","key":"15600_CR48","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF02899281","volume":"63","author":"HP Vollmers","year":"1993","unstructured":"Vollmers HP, et al. Characterization of four new gastric cancer cell lines. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;63(6):335\u201343.","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"15600_CR49","doi-asserted-by":"crossref","first-page":"122298","DOI":"10.1016\/j.biomaterials.2023.122298","volume":"302","author":"A Billet","year":"2023","unstructured":"Billet A, et al. A synthetic delivery vector for mucosal vaccination. Biomaterials. 2023;302:122298.","journal-title":"Biomaterials"},{"issue":"24","key":"15600_CR50","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1002\/rcm.2241","volume":"19","author":"I Meisen","year":"2005","unstructured":"Meisen I, et al. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. Rapid Commun Mass Spectrom. 2005;19(24):3659\u201365.","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"10","key":"15600_CR51","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1021\/acs.analchem.0c00480","volume":"92","author":"T Bien","year":"2020","unstructured":"Bien T, et al. MALDI-2 mass spectrometry and immunohistochemistry imaging of Gb3Cer, Gb4Cer, and further glycosphingolipids in human colorectal cancer tissue. Anal Chem. 2020;92(10):7096\u2013105.","journal-title":"Anal Chem"},{"issue":"1","key":"15600_CR52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2018.08.007","volume":"7","author":"FC Franke","year":"2019","unstructured":"Franke FC, et al. The tumor suppressor SASH1 interacts with the signal adaptor CRKL to inhibit epithelial-mesenchymal transition and metastasis in colorectal cancer. Cell Mol Gastroenterol Hepatol. 2019;7(1):33\u201353.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"15600_CR53","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.32955","volume":"147","author":"FC Franke","year":"2020","unstructured":"Franke FC, et al. Novel role for CRK adaptor proteins as essential components of SRC\/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness. Int J Cancer. 2020;147(6):1715\u201331.","journal-title":"Int J Cancer"},{"issue":"11","key":"15600_CR54","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8(11):2281\u2013308.","journal-title":"Nat Protoc"},{"issue":"5","key":"15600_CR55","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/SLA.0b013e318272de87","volume":"256","author":"U Nitsche","year":"2012","unstructured":"Nitsche U, et al. Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer. Ann Surg. 2012;256(5):763\u201371; discussion 771.","journal-title":"Ann Surg"},{"issue":"8","key":"15600_CR56","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/cells13080706","volume":"13","author":"N Fekete","year":"2024","unstructured":"Fekete N, et al. Flow cytometry-based assay to detect alpha galactosidase enzymatic activity at the cellular level. Cells. 2024;13(8):706.","journal-title":"Cells"},{"issue":"43","key":"15600_CR57","doi-asserted-by":"crossref","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Bryan MA J, Chang W, McGowan LD, Fran\u00e7ois R, Grolemund G, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686.","journal-title":"J Open Source Softw"},{"key":"15600_CR58","doi-asserted-by":"publisher","unstructured":"Kassambara A. ggpubr: 'ggplot2' based publication ready plots. 2025;2025:10\u20137. https:\/\/doi.org\/10.32614\/CRAN.package.ggpubr.","DOI":"10.32614\/CRAN.package.ggpubr"},{"key":"15600_CR59","doi-asserted-by":"publisher","unstructured":"Charlotte Dawson. ggprism: a \u2018ggplot2\u2019 extension inspired by \u2018GraphPad Prism\u2019. R package version 1.0.7. 2025. https:\/\/cran.r-project.org\/package=ggprism. https:\/\/doi.org\/10.5281\/zenodo.4556067.","DOI":"10.5281\/zenodo.4556067"},{"key":"15600_CR60","doi-asserted-by":"publisher","unstructured":"Kassambara A. rstatix: pipe-friendly framework for basic statistical tests. 2025. https:\/\/doi.org\/10.32614\/CRAN.package.rstatix.","DOI":"10.32614\/CRAN.package.rstatix"},{"issue":"7539","key":"15600_CR61","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature14217","volume":"518","author":"D Leung","year":"2015","unstructured":"Leung D, et al. Integrative analysis of haplotype-resolved epigenomes across human tissues. Nature. 2015;518(7539):350\u20134.","journal-title":"Nature"},{"issue":"D1","key":"15600_CR62","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"C UniProt","year":"2023","unstructured":"UniProt C. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523\u201331.","journal-title":"Nucleic Acids Res"},{"key":"15600_CR63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1476-4598-9-145","volume":"9","author":"YY Liu","year":"2010","unstructured":"Liu YY, et al. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling. Mol Cancer. 2010;9:145.","journal-title":"Mol Cancer"},{"issue":"8","key":"15600_CR64","doi-asserted-by":"crossref","first-page":"e107238","DOI":"10.15252\/embj.2020107238","volume":"40","author":"R Rizzo","year":"2021","unstructured":"Rizzo R, et al. Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3. EMBO J. 2021;40(8):e107238.","journal-title":"EMBO J"},{"issue":"1","key":"15600_CR65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, et al. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discov. 2024;10(1):28.","journal-title":"Cell Death Discov"},{"issue":"45","key":"15600_CR66","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.18632\/oncotarget.27795","volume":"11","author":"YG Amaar","year":"2020","unstructured":"Amaar YG, Reeves ME. The impact of the RASSF1C and PIWIL1 on DNA methylation: the identification of GMIP as a tumor suppressor. Oncotarget. 2020;11(45):4082\u201392.","journal-title":"Oncotarget"},{"key":"15600_CR67","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3389\/fonc.2020.00732","volume":"10","author":"T Zhang","year":"2020","unstructured":"Zhang T, et al. Differential o- and glycosphingolipid glycosylation in human pancreatic adenocarcinoma cells with opposite morphology and metastatic behavior. Front Oncol. 2020;10:732.","journal-title":"Front Oncol"},{"issue":"3","key":"15600_CR68","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/cells10030653","volume":"10","author":"M Oshi","year":"2021","unstructured":"Oshi M, et al. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), cell proliferation, prognosis, and drug response in pancreatic cancer. Cells. 2021;10(3):653.","journal-title":"Cells"},{"issue":"3","key":"15600_CR69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7150\/ijbs.14952","volume":"12","author":"JP Smith","year":"2016","unstructured":"Smith JP, Fonkoua LK, Moody TW. The role of gastrin and CCK receptors in pancreatic cancer and other malignancies. Int J Biol Sci. 2016;12(3):283\u201391.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"15600_CR70","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/carcin\/bgac069","volume":"43","author":"S Li","year":"2022","unstructured":"Li S, et al. Elevated expression of the membrane-anchored serine protease TMPRSS11E in NSCLC progression. Carcinogenesis. 2022;43(11):1092\u2013102.","journal-title":"Carcinogenesis"},{"key":"15600_CR71","doi-asserted-by":"crossref","first-page":"908943","DOI":"10.3389\/fonc.2022.908943","volume":"12","author":"F Fang","year":"2022","unstructured":"Fang F, et al. The role of SETBP1 in gastric cancer: friend or foe. Front Oncol. 2022;12:908943.","journal-title":"Front Oncol"},{"issue":"10","key":"15600_CR72","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3390\/biom10101393","volume":"10","author":"AJ Snider","year":"2020","unstructured":"Snider AJ, et al. Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status. Biomolecules. 2020;10(10):1393.","journal-title":"Biomolecules"},{"issue":"4","key":"15600_CR73","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/biomedicines10040732","volume":"10","author":"L Garc\u00eda-Hevia","year":"2022","unstructured":"Garc\u00eda-Hevia L, et al. Gb3\/cd77 is a predictive marker and promising therapeutic target for head and neck cancer. Biomedicines. 2022;10(4):732.","journal-title":"Biomedicines"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15600-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15600-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15600-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:11:41Z","timestamp":1781629901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15600-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15600"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15600-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study with a retrospective colorectal cancer cohort (CRC cohort) was approved by the Ethical Committee of the School of Medicine and Health, TUM (#1926\/07 and #5428\/12). The study complied with the 1975 Declaration of Helsinki, as revised in 1983. All participants provided written informed consent for the scientific use of their clinical data and samples. This study also used publicly available datasets obtained from the Gene Expression Omnibus (GEO), accessible under the accession GSE57342, and chromatin accessibility data for established cell lines under GSE186589, and no ethical approvals were required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"274"}}